Neuberger Berman Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.5M | Buy |
60,300
+11,530
| +24% | +$2.87M | 0.01% | 748 |
|
|
2025
Q4 | $11.7M | Sell |
48,770
-12,189
| -20% | -$3.12M | 0.01% | 765 |
|
|
2025
Q3 | $16.7M | Buy |
60,959
+7,043
| +13% | +$1.92M | 0.01% | 699 |
|
|
2025
Q2 | $13.9M | Buy |
53,916
+22,431
| +71% | +$5.35M | 0.01% | 721 |
|
|
2025
Q1 | $7.05M | Buy |
31,485
+4,855
| +18% | +$1.13M | 0.01% | 856 |
|
|
2024
Q4 | $6.09M | Buy |
26,630
+7,586
| +40% | +$1.83M | ﹤0.01% | 912 |
|
|
2024
Q3 | $4.65M | Buy |
19,044
+11,368
| +148% | +$2.54M | ﹤0.01% | 959 |
|
|
2024
Q2 | $1.47M | Sell |
7,676
-169
| -2% | -$34.3K | ﹤0.01% | 1178 |
|
|
2024
Q1 | $1.55M | Buy |
7,845
+475
| +6% | +$87K | ﹤0.01% | 1172 |
|
|
2023
Q4 | $1.27M | Buy |
7,370
+1,399
| +23% | +$215K | ﹤0.01% | 1214 |
|
|
2023
Q3 | $883K | Sell |
5,971
-6,011
| -50% | -$1.09M | ﹤0.01% | 1294 |
|
|
2023
Q2 | $2.62M | Sell |
11,982
-588
| -5% | -$131K | ﹤0.01% | 1022 |
|
|
2023
Q1 | $2.75M | Sell |
12,570
-3,543
| -22% | -$769K | ﹤0.01% | 1004 |
|
|
2022
Q4 | $3.35M | Sell |
16,113
-281
| -2% | -$61.7K | ﹤0.01% | 957 |
|
|
2022
Q3 | $3.58M | Sell |
16,394
-2,526
| -13% | -$575K | ﹤0.01% | 958 |
|
|
2022
Q2 | $3.97M | Sell |
18,920
-2,331
| -11% | -$496K | ﹤0.01% | 954 |
|
|
2022
Q1 | $5.15M | Buy |
21,251
+2,204
| +12% | +$533K | ﹤0.01% | 954 |
|
|
2021
Q4 | $4.46M | Buy |
19,047
+4,996
| +36% | +$1.3M | ﹤0.01% | 1008 |
|
|
2021
Q3 | $3.39M | Buy |
14,051
+2,136
| +18% | +$584K | ﹤0.01% | 1047 |
|
|
2021
Q2 | $2.75M | Sell |
11,915
-7,087
| -37% | -$1.49M | ﹤0.01% | 1106 |
|
|
2021
Q1 | $3.6M | Buy |
19,002
+3,149
| +20% | +$631K | ﹤0.01% | 1024 |
|
|
2020
Q4 | $3.33M | Buy |
15,853
+5,583
| +54% | +$1.11M | ﹤0.01% | 1012 |
|
|
2020
Q3 | $1.75M | Buy |
10,270
+1,779
| +21% | +$329K | ﹤0.01% | 1083 |
|
|
2020
Q2 | $1.62M | Sell |
8,491
-493
| -5% | -$80.7K | ﹤0.01% | 1051 |
|
|
2020
Q1 | $1.32M | Sell |
8,984
-181
| -2% | -$28.8K | ﹤0.01% | 1040 |
|
|
2019
Q4 | $1.42M | Buy |
9,165
+1,179
| +15% | +$170K | ﹤0.01% | 1091 |
|
|
2019
Q3 | $1.08M | Buy |
7,986
+1,147
| +17% | +$150K | ﹤0.01% | 1138 |
|
|
2019
Q2 | $835K | Buy |
6,839
+1,837
| +37% | +$203K | ﹤0.01% | 1195 |
|
|
2019
Q1 | $520K | Buy |
5,002
+1,717
| +52% | +$177K | ﹤0.01% | 1242 |
|
|
2018
Q4 | $374K | Hold |
3,285
| – | – | ﹤0.01% | 1316 |
|
|
2018
Q3 | $379K | Sell |
3,285
-148
| -4% | -$16.2K | ﹤0.01% | 1374 |
|
|
2018
Q2 | $356K | Buy |
3,433
+797
| +30% | +$80.6K | ﹤0.01% | 1461 |
|
|
2018
Q1 | $260K | Sell |
2,636
-26
| -1% | -$2.46K | ﹤0.01% | 1529 |
|
|
2017
Q4 | $225K | Buy |
+2,662
| New | +$220K | ﹤0.01% | 1656 |
|
Other funds holding RMD
VCM
VPM
DAM
Neuberger Berman Group's RMD Position: Q1 2026 in Review
Neuberger Berman Group increased its ResMed (RMD) stake by 24% in Q1 2026, buying an estimated $2.87M and bringing the position to 60,300 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #748.
Neuberger Berman Group first reported a position in RMD in Q4 2017 and has held it in 34 quarters since. The position peaked at $16.7M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Neuberger Berman Group held 60,300 shares of ResMed worth $13.5M as of Q1 2026.
- Neuberger Berman Group bought 11,530 ResMed shares in Q1 2026, an estimated $2.87M.
- ResMed made up 0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #748 holding.
- Neuberger Berman Group first reported a position in ResMed in Q4 2017 and has held it in 34 quarters since.
- Neuberger Berman Group's ResMed position peaked at $16.7M in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.